now stronger from the vaccine, started attacking the TB infection too aggressively, causing inflammation and the flare-up of symptoms. He was diagnosed with tuberculosis immune reconstitution ...

On April 18, 2025, LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company") successfully held the 2025 CSO ("Contract Sales Organization") Annual Meeting and the launch ...